de
Performance
Financial Reports
Press Releases
Share Buyback Programme
Factsheets
Securities
Management Transactions
Disclosure of Shareholdings
Company Presentation
Calendar
FAQ
News Registration
Contact
News Registration
Yes, I would like to receive news by email.
Title
Mr
Mrs
First name*
Last name*
Company
Email*
Phone
Address
Code
City
Country*
Please fill in this code*
*mandatory
You can
unsubscribe
at any time.
For sending us a message, please use the
contact form
.
News
Press Releases
»
HBM BioVentures Quarterly Report as at 30 June 2010
»
HBM BioVentures’ largest public investment – Micrus – acquired
by Johnson & Johnson
»
HBM BioVentures sells USD hedging position at a profit
»
Shareholders’ meeting approves all proposals by Board of Directors by large majority; Hans Peter Hasler appointed as new Chairman of the Board of Directors; Astellas, which recently acquired OSI Pharmaceuticals, will retain HBM BioVentures shares and intensify cooperation
»
Archive
Financial Reports
»
Quarterly Report June 2010
»
Annual Report 2009/2010
»
Archive
Share Price
SIX Swiss Exchange Ticker
HBMN
Key Figures
as at 31.8.2010
CHF
NAV
per share
62.58
Net assets
616 Mio.
Search
News Registration
Sign up now